N-palmitoyl-d-glucosamine limits mucosal damage and VEGF-mediated angiogenesis by PPARα-dependent suppression of pAkt/mTOR/HIF1α pathway and increase in PEA levels in AOM/DSS colorectal carcinoma in mice.
ALIAmides
VEGF
angiogenesis
colorectal carcinoma
mPGA
pAkt/mTOR/HIF1α
Journal
Phytotherapy research : PTR
ISSN: 1099-1573
Titre abrégé: Phytother Res
Pays: England
ID NLM: 8904486
Informations de publication
Date de publication:
05 Sep 2024
05 Sep 2024
Historique:
revised:
15
07
2024
received:
24
05
2024
accepted:
18
07
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
5
9
2024
Statut:
aheadofprint
Résumé
Chronic intestinal inflammation and neo-angiogenesis are interconnected in colorectal carcinoma (CRC) pathogenesis. Molecules reducing inflammation and angiogenesis hold promise for CRC prevention and treatment. N-Palmitoyl-d-glucosamine (PGA), a natural glycolipid analog with anti-inflammatory properties, has shown efficacy against acute colitis. Micronized PGA (mPGA) formulations exhibit superior anti-inflammatory activity. This study investigates the in vivo anti-angiogenic and protective effects of mPGA in a mouse model of colitis-associated CRC induced by azoxymethane/dextran sodium sulfate (AOM/DSS). CRC was induced in C57BL/6J mice using intraperitoneal azoxymethane followed by three cycles of 2.5% dextran sodium sulfate (DSS) in drinking water. Mice were treated with mPGA (30-150 mg/kg) with or without the PPARα inhibitor MK886 (10 mg/kg). At Day 70 post-azoxymethane injection, mice underwent anesthetized endoscopic colon evaluation. Post-mortem analysis of tumorigenesis and angiogenesis was performed using histological, immunohistochemical, and immunoblotting techniques. mPGA improved disease progression and survival rates in a dose- and PPARα-dependent manner in AOM/DSS-exposed mice. It reduced polyp formation, decreased pro-angiogenic CD31, pro-proliferative Ki67, and pro-inflammatory TLR4 expression levels, and inhibited VEGF and MMP-9 secretion by disrupting the pAkt/mTOR/HIF1α pathway. mPGA increased colon PEA levels, restoring anti-tumoral PPARα and wtp53 protein expression. Given its lack of toxicity, mPGA shows potential as a nutritional intervention to counteract inflammation-related angiogenesis in CRC.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Phytotherapy Research published by John Wiley & Sons Ltd.
Références
Acikalin, M. F., Oner, U., Topçu, I., Yaşar, B., Kiper, H., & Colak, E. (2005). Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Digestive and Liver Disease, 37(3), 162–169. https://doi.org/10.1016/j.dld.2004.09.028
Aguilar‐Cazares, D., Chavez‐Dominguez, R., Carlos‐Reyes, A., Lopez‐Camarillo, C., Hernadez de la Cruz, O. N., & Lopez‐Gonzalez, J. S. (2019). Contribution of angiogenesis to inflammation and cancer. Frontiers in Oncology, 9, 1399. https://doi.org/10.3389/fonc.2019.01399
Aloe, L., Leon, A., & Levi‐Montalcini, R. (1993). A proposed autacoid mechanism controlling mastocyte behaviour. Agents and Actions, 39, C145–C147. https://doi.org/10.1007/BF01972748
Becker, C., Fantini, M. C., & Neurath, M. F. (2006). High resolution colonoscopy in live mice. Nature Protocols, 1(6), 2900–2904. https://doi.org/10.1038/nprot.2006.446
Borrelli, F., Romano, B., Petrosino, S., Pagano, E., Capasso, R., Coppola, D., Battista, G., Orlando, P., Di Marzo, V., & Izzo, A. A. (2015). Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti‐inflammatory agent. British Journal of Pharmacology, 172(1), 142–158. https://doi.org/10.1111/bph.12907
Chiurchiù, V., Leuti, A., Smoum, R., Mechoulam, R., & Maccarrone, M. (2018). Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes. The FASEB Journal, 32(10), 5716–5723. https://doi.org/10.1096/fj.201800107R
Cordaro, M., Siracusa, R., Impellizzeri, D., D' Amico, R., Peritore, A. F., Crupi, R., Gugliandolo, E., Fusco, R., Di Paola, R., Schievano, C., & Cuzzocrea, S. (2019). Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain. Arthritis Research & Therapy, 21(1), 254. https://doi.org/10.1186/s13075-019-2048-y
Dzhalilova, D., Zolotova, N., Fokichev, N., & Makarova, O. (2023). Murine models of colorectal cancer: The azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis‐associated cancer. PeerJ, 31(11), e16159. https://doi.org/10.7717/peerj.16159
Fukata, M., Chen, A., Vamadevan, A. S., Cohen, J., Breglio, K., Krishnareddy, S., Hsu, D., Xu, R., Harpaz, N., Dannenberg, A. J., Subbaramaiah, K., Cooper, H. S., Itzkowitz, S. H., & Abreu, M. T. (2007). Toll‐like receptor‐4 promotes the development of colitis‐associated colorectal tumors. Gastroenterology, 133(6), 1869–1881. https://doi.org/10.1053/j.gastro.2007.09.008
Gachet, M. S., Rhyn, P., Bosch, O. G., Quednow, B. B., & Gertsch, J. (2015). A quantitiative LC‐MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N‐acylethanolamines and steroids in human plasma. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 976–977, 6–18. https://doi.org/10.1016/j.jchromb.2014.11.001
Gugliandolo, E., Peritore, A. F., Piras, C., Cuzzocrea, S., & Crupi, R. (2020). Palmitoylethanolamide and related ALIAmides: Prohomeostatic lipid compounds for animal health and wellbeing. Veterinary Sciences, 7(2), 78. https://doi.org/10.3390/vetsci7020078
Hu, X., Fatima, S., Chen, M., Xu, K., Huang, C., Gong, R. H., Su, T., Wong, H. L. X., Bian, Z., & Kwan, H. Y. (2021). Toll‐like receptor 4 is a master regulator for colorectal cancer growth under high‐fat diet by programming cancer metabolism. Cell Death & Disease, 12(8), 791. https://doi.org/10.1038/s41419-021-04076-x
Iannotta, M., Belardo, C., Trotta, M. C., Iannotti, F. A., Vitale, R. M., Maisto, R., Boccella, S., Infantino, R., Ricciardi, F., Mirto, B. F., Ferraraccio, F., Panarese, I., Amodeo, P., Tunisi, L., Cristino, L., D'Amico, M., Di Marzo, V., Luongo, L., Maione, S., & Guida, F. (2021). N‐palmitoyl‐D‐glucosamine, a natural monosaccharide‐based glycolipid, inhibits TLR4 and prevents LPS‐induced inflammation and neuropathic pain in mice. International Journal of Molecular Sciences, 22(3), 1491. https://doi.org/10.3390/ijms22031491
Janakiram, N. B., & Rao, C. V. (2014). The role of inflammation in colon cancer. Advances in Experimental Medicine and Biology, 816, 25–52. https://doi.org/10.1007/978-3-0348-0837-8_2
Jensen, A. B., Larsen, M., Gislum, M., Skriver, M. V., Jepsen, P., Nørgaard, B., & Sørensen, H. T. (2006). Survival after colorectal cancer in patients with ulcerative colitis: A nationwide population‐based Danish study. The American Journal of Gastroenterology, 101(6), 1283–1287. https://doi.org/10.1111/j.1572-0241.2006.00520.x
Kaipainen, A., Kieran, M. W., Huang, S., Butterfield, C., Bielenberg, D., Mostoslavsky, G., Mulligan, R., Folkman, J., & Panigrahy, D. (2007). PPARalpha deficiency in inflammatory cells suppresses tumor growth. PLoS One, 2(2), e260. https://doi.org/10.1371/journal.pone.0000260
Koroukian, S. M., Booker, B. D., Vu, L., Schumacher, F. R., Rose, J., Cooper, G. S., Selfridge, J. E., & Markt, S. C. (2023). Receipt of targeted therapy and survival outcomes in patients with metastatic colorectal cancer. JAMA Network Open, 6(1), e2250030. https://doi.org/10.1001/jamanetworkopen.2022.50030
Kumar, A., Gautam, V., Sandhu, A., Rawat, K., Sharma, A., & Saha, L. (2023). Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World Journal of Gastrointestinal Surgery, 15(4), 495–519. https://doi.org/10.4240/wjgs.v15.i4.495
Leiphrakpam, P. D., & Are, C. (2024). PI3K/Akt/mTOR signaling pathway as a target for colorectal cancer treatment. International Journal of Molecular Sciences, 25(6), 3178. https://doi.org/10.3390/ijms25063178
Li, R., Kim, M. H., Sandhu, A. K., Gao, C., & Gu, L. (2017). Muscadine grape (Vitis rotundifolia) or wine phytochemicals reduce intestinal inflammation in mice with dextran sulfate sodium‐induced colitis. Journal of Agricultural and Food Chemistry, 65(4), 769–776. https://doi.org/10.1021/acs.jafc.6b03806
Lichtenstern, C. R., Ngu, R. K., Shalapour, S., & Karin, M. (2020). Immunotherapy, inflammation and colorectal cancer. Cells, 9(3), 618. https://doi.org/10.3390/cells9030618
Liu, X., Li, X., Wei, H., Liu, Y., & Li, N. (2023). Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis. Frontiers in Immunology, 14, 1209056. https://doi.org/10.3389/fimmu.2023.1209056
Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005). The nuclear receptor peroxisome proliferator‐activated receptor‐alpha mediates the anti‐inflammatory actions of palmitoylethanolamide. Molecular Pharmacology, 67(1), 15–19. https://doi.org/10.1124/mol.104.006353
Luo, Y., Xie, C., Brocker, C. N., Fan, J., Wu, X., Feng, L., Wang, Q., Zhao, J., Lu, D., Tandon, M., Cam, M., Krausz, K. W., Liu, W., & Gonzalez, F. J. (2019). Intestinal PPARα protects against colon carcinogenesis via regulation of methyltransferases DNMT1 and PRMT6. Gastroenterology, 157(3), 744–759.e4. https://doi.org/10.1053/j.gastro.2019.05.057
Mandle, H. B., Jenab, M., Gunter, M. J., Tjønneland, A., Olsen, A., Dahm, C. C., Zhang, J., Sugier, P. E., Rothwell, J., Severi, G., Kaaks, R., Katzke, V. A., Schulze, M. B., Masala, G., Sieri, S., Panico, S., Sacerdote, C., Bonet, C., Sánchez, M. J., … Fedirko, V. (2024). Inflammation and gut barrier function‐related genes and colorectal cancer risk in Western European populations. Mutagenesis, 1–13, geae008. https://doi.org/10.1093/mutage/geae008
Palenca, I., Seguella, L., Del Re, A., Franzin, S. B., Corpetti, C., Pesce, M., Rurgo, S., Steardo, L., Sarnelli, G., & Esposito, G. (2022). N‐palmitoyl‐D‐glucosamine inhibits TLR‐4/NLRP3 and improves DNBS‐induced colon inflammation through a PPAR‐α‐dependent mechanism. Biomolecules, 12(8), 1163. https://doi.org/10.3390/biom12081163
Palenca, I., Seguella, L., Zilli, A., Basili Franzin, S., Del Re, A., Pepi, F., Troiani, A., Pesce, M., Rurgo, S., De Palma, F. D. E., Luglio, G., Tropeano, F. P., Sarnelli, G., & Esposito, G. (2023). Intrarectal Administration of Adelmidrol plus hyaluronic acid gel ameliorates experimental colitis in mice and inhibits pro‐inflammatory response in ex vivo cultured biopsies derived from ulcerative colitis‐affected patients. International Journal of Molecular Sciences, 25(1), 165. https://doi.org/10.3390/ijms25010165
Parang, B., Barrett, C. W., & Williams, C. S. (2016). AOM/DSS model of colitis‐associated cancer. Methods in Molecular Biology, 1422, 297–307. https://doi.org/10.1007/978-1-4939-36
Sarnelli, G., D'Alessandro, A., Iuvone, T., Capoccia, E., Gigli, S., Pesce, M., Seguella, L., Nobile, N., Aprea, G., Maione, F., de Palma, G. D., Cuomo, R., Steardo, L., & Esposito, G. (2016). Palmitoylethanolamide modulates inflammation‐associated vascular endothelial growth factor (VEGF) signaling via the Akt/mTOR pathway in a selective peroxisome proliferator‐activated receptor alpha (PPAR‐α)‐dependent manner. PLoS One, 11(5), e0156198. https://doi.org/10.1371/journal.pone.0156198
Sarnelli, G., Gigli, S., Capoccia, E., Iuvone, T., Cirillo, C., Seguella, L., Nobile, N., D'Alessandro, A., Pesce, M., Steardo, L., Cuomo, R., & Esposito, G. (2016). Palmitoylethanolamide exerts antiproliferative effect and downregulates VEGF signaling in Caco‐2 human colon carcinoma cell line through a selective PPAR‐α‐dependent inhibition of Akt/mTOR pathway. Phytotherapy Research, 30(6), 963–970. https://doi.org/10.1002/ptr.5601
Sato, Y., Tsujinaka, S., Miura, T., Kitamura, Y., Suzuki, H., & Shibata, C. (2023). Inflammatory bowel disease and colorectal cancer: Epidemiology, etiology, surveillance, and management. Cancers, 15(16), 4154. https://doi.org/10.3390/cancers15164154
Schweiger, V., Martini, A., Bellamoli, P., Donadello, K., Schievano, C., Balzo, G. D., Sarzi‐Puttini, P., Parolini, M., & Polati, E. (2019). Ultramicronized Palmitoylethanolamide (um‐PEA) as add‐on treatment in fibromyalgia syndrome (FMS): Retrospective observational study on 407 patients. CNS & Neurological Disorders Drug Targets, 18(4), 326–333. https://doi.org/10.2174/1871527318666190227205359
Simon, K. (2016). Colorectal cancer development and advances in screening. Clinical Interventions in Aging, 11, 967–976. https://doi.org/10.2147/CIA.S109285
Singh, N., Baby, D., Rajguru, J. P., Patil, P. B., Thakkannavar, S. S., & Pujari, V. B. (2019). Inflammation and cancer. Annals of African Medicine, 18(3), 121–126. https://doi.org/10.4103/aam.aam_56_18
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Tsuji, S., Kawano, S., Hayashi, N., Tsujii, M., Takei, Y., Nagano, K., Sasayama, Y., Kobayashi, I., Fusamoto, H., & Kamada, T. (1995). Simultaneous analysis of mucosal and submucosal hemodynamics using infrared electronic endoscopy: Effects of intraluminal acid on ulcer scars. Endoscopy, 27(9), 679–682. https://doi.org/10.1055/s-2007-1005787
Yu, Y., Blokhuis, B., Derks, Y., Kumari, S., Garssen, J., & Redegeld, F. (2018). Human mast cells promote colon cancer growth via bidirectional crosstalk: Studies in 2D and 3D coculture models. Oncoimmunology, 7(11), e1504729. https://doi.org/10.1080/2162402X.2018.1504729
Zeineddine, F. A., Zeineddine, M. A., Yousef, A., Gu, Y., Chowdhury, S., Dasari, A., Huey, R. W., Johnson, B., Kee, B., Lee, M. S., Morelli, M. P., Morris, V. K., Overman, M. J., Parseghian, C., Raghav, K., Willis, J., Wolff, R. A., Kawaguchi, Y., Vauthey, J. N., … Shen, J. P. (2023). Survival improvement for patients with metastatic colorectal cancer over twenty years. NPJ Precision Oncology, 7(1), 16. https://doi.org/10.1038/s41698-023-00353-4